Analysis of intravitreal bevacizumab treatment for macular oedema due to retinal vein occlusion.
Szabolcs BallaEszter ZoldLaszlo PotorBalazs LukuczAttila VajasBernadett UjhelyiValeria NagyPublished in: European journal of ophthalmology (2020)
IVB treatment results in significantly better final visual acuity and leads to significantly increased BCVA improvement compared to patients with RVO-induced macular oedema receiving no treatment.